Juneja, R <br/><br/>
Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.  [electronic resource] 

 -  Metabolism: clinical and experimental  Sep 2001 
 - 1008-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0026-0495 
<br/><br/><label>Standard No.: </label>10.1053/meta.2001.25654  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Asian People<br/>Autoantibodies--blood<br/>Black People<br/>Body Mass Index<br/>Diabetes Mellitus, Type 1--blood<br/>Diabetes Mellitus, Type 2--diagnosis<br/>Diagnosis, Differential<br/>Female<br/>Glutamate Decarboxylase--immunology<br/>Humans<br/>Hyperglycemia--etiology<br/>Insulin--immunology<br/>Isoenzymes--immunology<br/>Male<br/>Middle Aged<br/>Phenotype<br/>Polyuria--etiology<br/>Predictive Value of Tests<br/>White People